Feb 25, 2022, 11:39

Cristina’s main research objective is to advance the understanding of drug resistance mechanisms in cancer thus improving current cancer treatments. She started to pursue this goal during her PhD studies in Molecular Biology at the University of Camerino, Italy, where she investigated how cancer cells evade immune system and therapies. During her PhD, she also collaborated with University of Geneva and Marche Polytechnic University studying metabolism and anti-oxidant mechanisms in muscles during aging. During these collaborations it became clear that aging and cancer share similar hallmarks, including altered oxidative stress response and metabolism. Cristina became interested in studying how these processes might affect tumorigenesis and response to cancer therapy. After receiving her PhD, Cristina joined Scaglioni’s lab to continue research on drug resistance in lung cancer, and has focused her efforts on elucidating the relationship between lipid metabolism and drug resistance in mutant KRAS lung cancer.

Name : Cristina Andreani, PhD

Title :

Email :

Description 1 :

Description 2 :

Description 3 :